UCSD's Dr. Davey Smith, former ACTIV-2 Protocol Chair, endorses 'Xafty' as 'The weapon to end the virus war.' - Announces ...
Invivyd has launched its DECLARATION Phase 3 pivotal trial for VYD2311, a monoclonal antibody designed as an alternative to ...
16mon MSN
BMC election result LIVE: BJP+ hits majority mark in 'Hindutva' vs 'Marathi Manoos' fight in BMC
Prime Minister Narendra Modi thanked voters of Maharashtra as Mahayuti alliance heads towards landslide win in the state's ...
Expects 2025 revenue of approximately $1.9 billion (unaudited), $100 million above midpoint communicated on 3Q25 ...
It was the priciest biotech startup sale in North Carolina history. Now five years under Bayer, AskBio advances more AAV gene ...
SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
BioNTech with continued late-stage pipeline progress with candidates across immunomodulators, antibody-drug conjugates and mRNA immunotherapiesExpected 2026 oncology ...
Aiming to facilitate large-scale indigenous manufacturing, this device will secure regulatory approvals, and facilitate the ...
It comes after weeks of criticism from pub bosses, industry chiefs and politicians over changes to business rates in the ...
After the city reduced its funding award to the Douglas County Housing Stabilization Collaborative, the organization that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback